Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002164643 | SCV002333340 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 7 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045003 | SCV003913750 | uncertain significance | not specified | 2023-02-02 | criteria provided, single submitter | clinical testing | The p.D385H variant (also known as c.1153G>C), located in coding exon 1 of the MLH3 gene, results from a G to C substitution at nucleotide position 1153. The aspartic acid at codon 385 is replaced by histidine, an amino acid with similar properties. This alteration was detected in 0/30 probands with colorectal cancer and 1/90 cancer-free controls (Hienonen T et al. Int J Cancer, 2003 Aug;106:292-6). This amino acid position is not well conserved in available vertebrate species, and histidine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |
Center for Genomic Medicine, |
RCV004045003 | SCV005872866 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing |